These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 39214010)

  • 1. Long noncoding RNAs as potential targets for overcoming chemoresistance in upper gastrointestinal cancers.
    Vaghari-Tabari M; Qujeq D; Hashemzadeh MS
    Biomed Pharmacother; 2024 Oct; 179():117368. PubMed ID: 39214010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosstalk between lncRNAs and miRNAs in gastrointestinal cancer drug resistance.
    Raei N; Safaralizadeh R; Hesseinpourfeizi M; Yazdanbod A; Pourfarzi F; Latifi-Navid S
    Life Sci; 2021 Nov; 284():119933. PubMed ID: 34508759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of the Hedgehog Pathway in Chemoresistance of Gastrointestinal Cancers.
    Liang Y; Yang L; Xie J
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNAs as a determinant of cancer drug resistance: Towards the overcoming of chemoresistance via modulation of lncRNAs.
    Jiang W; Xia J; Xie S; Zou R; Pan S; Wang ZW; Assaraf YG; Zhu X
    Drug Resist Updat; 2020 May; 50():100683. PubMed ID: 32146422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of long non-coding RNAs in mediating chemoresistance by modulating autophagy in cancer.
    Jin KT; Lu ZB; Lv JQ; Zhang JG
    RNA Biol; 2020 Dec; 17(12):1727-1740. PubMed ID: 32129701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability.
    Eptaminitaki GC; Stellas D; Bonavida B; Baritaki S
    Drug Resist Updat; 2022 Dec; 65():100866. PubMed ID: 36198236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNAs in anti-cancer drug resistance.
    Chen QN; Wei CC; Wang ZX; Sun M
    Oncotarget; 2017 Jan; 8(1):1925-1936. PubMed ID: 27713133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia and lncRNAs in gastrointestinal cancers.
    Huang L; Wang W; Hu Z; Guan C; Li W; Jiang X
    Pathol Res Pract; 2019 Dec; 215(12):152687. PubMed ID: 31640897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The emerging role of noncoding RNAs in colorectal cancer chemoresistance.
    Wei L; Wang X; Lv L; Zheng Y; Zhang N; Yang M
    Cell Oncol (Dordr); 2019 Dec; 42(6):757-768. PubMed ID: 31359293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Competitive endogenous network of lncRNA, miRNA, and mRNA in the chemoresistance of gastrointestinal tract adenocarcinomas.
    Raziq K; Cai M; Dong K; Wang P; Afrifa J; Fu S
    Biomed Pharmacother; 2020 Oct; 130():110570. PubMed ID: 32763816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential roles of exosome non‑coding RNAs in cancer chemoresistance (Review).
    Wang Y; Liu Q; Wang F
    Oncol Rep; 2021 Feb; 45(2):439-447. PubMed ID: 33416168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNAs as biotargets in cisplatin-based drug resistance.
    Abu N; Hon KW; Jeyaraman S; Jamal R
    Future Oncol; 2018 Dec; 14(29):3085-3095. PubMed ID: 30468082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The underlying mechanisms of non-coding RNAs in the chemoresistance of pancreatic cancer.
    Xiong G; Feng M; Yang G; Zheng S; Song X; Cao Z; You L; Zheng L; Hu Y; Zhang T; Zhao Y
    Cancer Lett; 2017 Jul; 397():94-102. PubMed ID: 28254409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging role of long non-coding RNAs in cancer chemoresistance: unravelling the multifaceted role and prospective therapeutic targeting.
    Singh D; Khan MA; Siddique HR
    Mol Biol Rep; 2020 Jul; 47(7):5569-5585. PubMed ID: 32601922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNAs in gastrointestinal cancers: Implications for protein phosphorylation.
    Su T; Wang T; Zhang N; Shen Y; Li W; Xing H; Yang M
    Biochem Pharmacol; 2022 Mar; 197():114907. PubMed ID: 35007523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction/reversal of drug resistance in gastric cancer by non-coding RNAs (Review).
    Chen C; Tang X; Liu Y; Zhu J; Liu J
    Int J Oncol; 2019 May; 54(5):1511-1524. PubMed ID: 30896792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNAs; potential contributors in cancer chemoresistance through modulating diverse molecular mechanisms and signaling pathways.
    Alsaab HO; Alzahrani MS; F Alaqile A; Waggas DS; Almutairy B
    Pathol Res Pract; 2024 Aug; 260():155455. PubMed ID: 39043005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advances in research on gastrointestinal cancer-associated long non-coding RNAs].
    Ge J; Pang Q; Guo J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Apr; 32(2):284-7. PubMed ID: 25863105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Updated Review of the Contribution of Noncoding RNAs to the Progression of Gastric Cancer Stem Cells: Molecular Mechanisms of Viability, Invasion, and Chemoresistance of Gastric Cancer Stem Cells.
    Dastmalchi N; Safaralizadeh R; Teimourian S
    Curr Stem Cell Res Ther; 2022; 17(5):440-445. PubMed ID: 35081895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic Role of Exosomal Circular and Long Noncoding RNAs in Gastrointestinal Cancers.
    Yun BD; Choi YJ; Son SW; Cipolla GA; Berti FCB; Malheiros D; Oh TJ; Kuh HJ; Choi SY; Park JK
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.